从免疫疗法角度对甲状腺癌的新兴见解:一封信函
Zheng Zhang1, Zhao-Nan Zhang1, Zhen-Xi Xu1
1Cancer Center, Yantai Affiliated Hospital of Binzhou Medical University, The 2nd Medical College of Binzhou Medical University, Yantai, China.
Human vaccines & immunotherapeutics
|March 3, 2025
概括
这项研究完善了甲状腺癌免疫疗法研究方法,确定了出版趋势和全球合作. 一个分析平台有助于未来的研究和临床翻译.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 图书统计学 图书统计学
- 数据科学数据科学数据科学
背景情况:
- 以前对甲状腺癌免疫治疗的研究面临数据检索限制.
- 精确的搜索策略对于准确的文献识别分析在这个领域至关重要.
研究的目的:
- 加强对甲状腺癌免疫疗法研究的文献分析.
- 通过图库计量和机器学习绘制研究演变的地图.
- 为数据再利用和知识差距识别提供一个开放式访问平台.
主要方法:
- 在Web of Science核心集合中实施了精细的搜索策略.
- 有针对性的关键字段 (标题,摘要,作者关键字) 与增强的术语.
- 用机器学习进行综合图库分析,用于趋势映射和预测建模.
主要成果:
- 确定了578个出版物,比之前的研究增加了41%.
- 揭示了2017年后出版物的激增,表明研究兴趣日益增长.
- 突出全球合作模式和高影响力研究集群.
结论:
- 提高搜索精度显著影响了癌症研究中的文献计量结果.
- 该研究绘制了甲状腺癌免疫治疗的演变图,强调新兴疗法.
- 一个开放式访问平台加速了免疫疗法进步的转化到临床实践中.
相关概念视频
Tumor Immunotherapy
461
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
461
Cancer Vaccines
324
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
324
Cytotoxic T Cells-mediated Immune Response
825
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
825
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K


